These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38956130)

  • 21. Impaired glutamate recycling and GluN2B-mediated neuronal calcium overload in mice lacking TGF-β1 in the CNS.
    Koeglsperger T; Li S; Brenneis C; Saulnier JL; Mayo L; Carrier Y; Selkoe DJ; Weiner HL
    Glia; 2013 Jun; 61(6):985-1002. PubMed ID: 23536313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NMDA receptors mediate synaptic depression, but not spine loss in the dentate gyrus of adult amyloid Beta (Aβ) overexpressing mice.
    Müller MK; Jacobi E; Sakimura K; Malinow R; von Engelhardt J
    Acta Neuropathol Commun; 2018 Oct; 6(1):110. PubMed ID: 30352630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deletion of Dtnbp1 in mice impairs threat memory consolidation and is associated with enhanced inhibitory drive in the amygdala.
    Huang CCY; Muszynski KJ; Bolshakov VY; Balu DT
    Transl Psychiatry; 2019 Apr; 9(1):132. PubMed ID: 30967545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Novel Human
    Stephenson JR; Wang X; Perfitt TL; Parrish WP; Shonesy BC; Marks CR; Mortlock DP; Nakagawa T; Sutcliffe JS; Colbran RJ
    J Neurosci; 2017 Feb; 37(8):2216-2233. PubMed ID: 28130356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Rare Variant Identified Within the GluN2B C-Terminus in a Patient with Autism Affects NMDA Receptor Surface Expression and Spine Density.
    Liu S; Zhou L; Yuan H; Vieira M; Sanz-Clemente A; Badger JD; Lu W; Traynelis SF; Roche KW
    J Neurosci; 2017 Apr; 37(15):4093-4102. PubMed ID: 28283559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The CaMKII/NMDA receptor complex controls hippocampal synaptic transmission by kinase-dependent and independent mechanisms.
    Incontro S; Díaz-Alonso J; Iafrati J; Vieira M; Asensio CS; Sohal VS; Roche KW; Bender KJ; Nicoll RA
    Nat Commun; 2018 May; 9(1):2069. PubMed ID: 29802289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subchronic pharmacological and chronic genetic NMDA receptor hypofunction differentially regulate the Akt signaling pathway and Arc expression in juvenile and adult mice.
    Takagi S; Balu DT; Coyle JT
    Schizophr Res; 2015 Mar; 162(1-3):216-21. PubMed ID: 25592804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ANKS1B Gene Product AIDA-1 Controls Hippocampal Synaptic Transmission by Regulating GluN2B Subunit Localization.
    Tindi JO; Chávez AE; Cvejic S; Calvo-Ochoa E; Castillo PE; Jordan BA
    J Neurosci; 2015 Jun; 35(24):8986-96. PubMed ID: 26085624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive enhancer ST101 improves schizophrenia-like behaviors in neonatal ventral hippocampus-lesioned rats in association with improved CaMKII/PKC pathway.
    Yabuki Y; Wu L; Fukunaga K
    J Pharmacol Sci; 2019 Jul; 140(3):263-272. PubMed ID: 31474557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlated alterations in serotonergic and dopaminergic modulations at the hippocampal mossy fiber synapse in mice lacking dysbindin.
    Kobayashi K; Umeda-Yano S; Yamamori H; Takeda M; Suzuki H; Hashimoto R
    PLoS One; 2011 Mar; 6(3):e18113. PubMed ID: 21448290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysbindin-1 modulates prefrontal cortical activity and schizophrenia-like behaviors via dopamine/D2 pathways.
    Papaleo F; Yang F; Garcia S; Chen J; Lu B; Crawley JN; Weinberger DR
    Mol Psychiatry; 2012 Jan; 17(1):85-98. PubMed ID: 20956979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of schizophrenia patients.
    Weickert CS; Rothmond DA; Hyde TM; Kleinman JE; Straub RE
    Schizophr Res; 2008 Jan; 98(1-3):105-10. PubMed ID: 17961984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia.
    Talbot K; Eidem WL; Tinsley CL; Benson MA; Thompson EW; Smith RJ; Hahn CG; Siegel SJ; Trojanowski JQ; Gur RE; Blake DJ; Arnold SE
    J Clin Invest; 2004 May; 113(9):1353-63. PubMed ID: 15124027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single point mutation on the gene encoding dysbindin results in recognition deficits.
    Chang EH; Fernando K; Yeung LWE; Barbari K; Chandon TS; Malhotra AK
    Genes Brain Behav; 2018 Jun; 17(5):e12449. PubMed ID: 29227583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MK-801 impairs working memory on the Trial-Unique Nonmatch-to-Location test in mice, but this is not exclusively mediated by NMDA receptors on PV+ interneurons or forebrain pyramidal cells.
    Sokolenko E; Nithianantharajah J; Jones NC
    Neuropharmacology; 2020 Jul; 171():108103. PubMed ID: 32330470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysbindin-1, WAVE2 and Abi-1 form a complex that regulates dendritic spine formation.
    Ito H; Morishita R; Shinoda T; Iwamoto I; Sudo K; Okamoto K; Nagata K
    Mol Psychiatry; 2010 Oct; 15(10):976-86. PubMed ID: 20531346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The sandy (sdy) mouse: a dysbindin-1 mutant relevant to schizophrenia research.
    Talbot K
    Prog Brain Res; 2009; 179():87-94. PubMed ID: 20302821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabidiol attenuates sensorimotor gating disruption and molecular changes induced by chronic antagonism of NMDA receptors in mice.
    Gomes FV; Issy AC; Ferreira FR; Viveros MP; Del Bel EA; Guimarães FS
    Int J Neuropsychopharmacol; 2014 Oct; 18(5):. PubMed ID: 25618402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitivity to MK-801 in phospholipase C-β1 knockout mice reveals a specific NMDA receptor deficit.
    Gray L; McOmish CE; Scarr E; Dean B; Hannan AJ
    Int J Neuropsychopharmacol; 2009 Aug; 12(7):917-28. PubMed ID: 19236734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Essential role of GluD1 in dendritic spine development and GluN2B to GluN2A NMDAR subunit switch in the cortex and hippocampus reveals ability of GluN2B inhibition in correcting hyperconnectivity.
    Gupta SC; Yadav R; Pavuluri R; Morley BJ; Stairs DJ; Dravid SM
    Neuropharmacology; 2015 Jun; 93():274-84. PubMed ID: 25721396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.